BUCAPSOL (buspirone hydrochloride) by Viatris (2) is clinical pharmacology the mechanism of action of buspirone is unknown. Approved for anxiety disorders, the short-term relief of the symptoms of anxiety, anxiety and 3 more indications. First approved in 2025.
Drug data last refreshed 18h ago
CLINICAL PHARMACOLOGY The mechanism of action of buspirone is unknown. Buspirone differs from typical benzodiazepine anxiolytics in that it does not exert anticonvulsant or muscle relaxant effects. It also lacks the prominent sedative effect that is associated with more typical anxiolytics. In…
Worked on BUCAPSOL at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Buspirone Hydrochloride 30mg Tablets, Non-Fasting
Buspirone Hydrochloride 30mg Tablets, Fasting